Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases

Completed

• Conditions: Metastatic Colorectal Cancer

• Registration Number: NCT02942901
• Lead Sponsor: Lung Clinic Heckeshorn

Brief Summary

Surgery has been available for the treatment of pulmonary metastases in metastatic colorectal cancer and promising overall survival was observed in retrospective studies with selected patients. This study investigated whether the preoperative FDG- PET/CT scan influences survival in this patient group. Furthermore, we tried to identify other prognostic factors associated with overall survival and progression-free survival.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-01
• Study First Submitted: 2016-10-21
• Study First Submitted QC: 2016-10-21
• Study First Posted: 2016-10-24
• Primary Completion: 2019-09-01
• Study Completion: 2020-01-01
• Status Verified: 2020-09
• Last Update Submitted: 2020-09-03
• Last Update Posted: 2020-09-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

• Patients over 18 years with pulmonary metastases eligible for pulmonary metastasectomy

Exclusion Criteria

• Second primary cancer within the last 2 years (exception basal cell carcinoma of the skin)
• Pregnancy,
• Drug addiction,
• Renal dialysis

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall Survival	5 years

Secondary Outcome Measures

Name	Time	Method
Number and sites of metastases detected by PET-CT	3 years

Trial Locations

Locations (1)

Lung Clinic Heckeshorn at HELIOS Hospital Emil von Behring; 🇩🇪 Berlin, Germany